Company Overview
SAREPTA THERAPEUTICS, INC.
SRPTRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
2,198M
2025 FY
Net Income
-713M
2025 FY
Shares Outstanding
100M
2025 FY
EPS
-7.13USD
2025 FY
Company Information
SIC Code
2834
CIK Code
873303
Exchange
Nasdaq
Location
US